You have 9 free searches left this month | for more free features.

Antibodies, Monoclonal

Showing 7326 - 7350 of 7,894

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in New York (biological, drug, procedure)

Completed
  • Leukemia
  • +4 more
  • alemtuzumab
  • +5 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Dec 3, 2012

Lung Cancer Trial in Canada, United States (biological, drug, radiation)

Terminated
  • Lung Cancer
  • monoclonal antibody 11D10 anti-idiotype vaccine
  • +4 more
  • Mobile, Alabama
  • +99 more
Jun 11, 2012

HLA Sensitization Following Major Cortical Allograft Bone

Completed
  • Bone Cancer
  • retrieve blood samples
  • Gainesville, Florida
    UF Orthopaedics and Sports Medicine Institute
Oct 26, 2012

Lymphoma Trial in Atlanta (Mitoxantrone/Cyclophosphamide, Fludarabine, Rituximab and GM-CSF)

Terminated
  • Lymphoma
  • Mitoxantrone/Cyclophosphamide, Fludarabine, Rituximab and GM-CSF
  • Atlanta, Georgia
    Emory University Winship Cancer Institute
May 25, 2012

Pancreatic Cancer Trial in San Francisco (biological, drug, procedure)

Terminated
  • Pancreatic Cancer
  • bevacizumab
  • +2 more
  • San Francisco, California
    UCSF Helen Diller Family Comprehensive Cancer Center
Sep 13, 2012

Ulcerative Colitis Trial in Herzlyia, Jerusalem, Qiryat Bialik (Adalimumab)

Unknown status
  • Ulcerative Colitis
  • Herzlyia, Israel
  • +2 more
Oct 28, 2012

Crohn Disease Trial in United States (semapimod, )

Terminated
  • Crohn Disease
  • San Diego, California
  • +12 more
Aug 22, 2012

Influenza Trial in Oxford (TIV and MVA-NP+M1, Saline and seasonal influenza vaccine TIV)

Completed
  • Influenza
  • TIV and MVA-NP+M1
  • Saline placebo and seasonal influenza vaccine TIV
  • Oxford, United Kingdom
    Centre for Clinical Vaccinology and Tropical Medicine, Churchill
Nov 28, 2012

Juvenile Rheumatoid Arthritis Trial in Japan (Adalimumab)

Completed
  • Juvenile Rheumatoid Arthritis
  • Adalimumab
  • Aichi, Japan
  • +11 more
Sep 5, 2012

HIV Trial in United States (KD-247, Physiological saline)

Completed
  • HIV Infections
  • Beverly Hills, California
  • +14 more
Nov 16, 2012

Anthrax Trial in San Antonio (AVP-21D9, Placebo)

Completed
  • Anthrax
  • San Antonio, Texas
    ICON Development Solutions
Nov 20, 2012

Psoriasis, Immunomodulation Trial in Little Rock (tofacitinib)

Completed
  • Psoriasis
  • Immunomodulation
  • Little Rock, Arkansas
    Pfizer Investigational Site
Jan 16, 2013

Breast Cancer Trial (external beam radiation therapy, Herceptin)

Completed
  • Breast Cancer
  • (no location specified)
Aug 14, 2012

Scleroderma Trial in United States (MEDI-546)

Completed
  • Scleroderma
  • Los Angeles, California
  • +10 more
May 7, 2012

Colorectal Cancer Trial in Cleveland (bevacizumab, erlotinib HCl, fluorouracil)

Completed
  • Colorectal Cancer
  • bevacizumab
  • +4 more
  • Cleveland, Ohio
  • +2 more
Aug 31, 2012

Leukemia Trial in Belgium, Italy, Netherlands (gemtuzumab ozogamicin)

Unknown status
  • Leukemia
  • gemtuzumab ozogamicin
  • Antwerp, Belgium
  • +44 more
Jul 23, 2012

Leukemia Trial in Worldwide (cytarabine, etoposide, gemtuzumab ozogamicin)

Completed
  • Leukemia
  • Innsbruck, Austria
  • +17 more
Jul 13, 2012

Influenza, Human Trial in Baltimore (TCN-032, Placebo)

Completed
  • Influenza, Human
  • TCN-032
  • Placebo
  • Baltimore, Maryland
    SNBL Clinical Pharmacology Center
Mar 30, 2012

Hematologic Malignancy Trial in Houston (drug, radiation, procedure)

Completed
  • Hematologic Malignancy
  • Houston, Texas
  • +1 more
Jun 27, 2012

Leukemia, MDS Trial in Worldwide (drug, procedure, radiation)

Completed
  • Leukemia
  • Myelodysplastic Syndromes
  • Brugge, Belgium
  • +8 more
Jul 13, 2012

Lung Cancer Trial in Worldwide (BCG vaccine, mAb BEC2)

Completed
  • Lung Cancer
  • BCG vaccine
  • monoclonal antibody BEC2
  • Birmingham, Alabama
  • +76 more
Mar 5, 2012

NSCLC Trial in United States (M200 (Volociximab), Carboplatin, Paclitaxel, Bevacizumab)

Completed
  • Non-small Cell Lung Cancer
  • M200 (Volociximab), Carboplatin, Paclitaxel, Bevacizumab
  • Bethesda, Maryland
  • +3 more
Apr 25, 2012

Stage III-IV or Recurrent Endometrial Cancer Trial in Rome, (Bevacizumab, Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8

Unknown status
  • Stage III-IV or Recurrent Endometrial Cancer
  • Bevacizumab
  • Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8 cycles
  • Rome,, Rome, Italy
    Catholic University of Sacred Heart Rome,
Jan 15, 2013

Alzheimer's Disease Trial in Worldwide (LY2062430, Placebo)

Completed
  • Alzheimer's Disease
  • Tucson, Arizona
  • +94 more
Dec 11, 2012

Breast Cancer Trial (trastuzumab, tipifarnib)

Withdrawn
  • Breast Cancer
  • (no location specified)
Jun 27, 2012